Posted On: 03/17/2015 12:55:04 PM
Post# of 30066
Yes, "We are there"
Amarantus Commences Launch of Proprietary Alzheimer's Blood Diagnostic LymPro Test(R) to Pharmaceutical Industry for Use in Clinical Trials
http://ir.amarantus.com/company-news/detail/1...cal-trials
Amarantus Announces First Alzheimer's Biomarker Services Collaboration for LymPro Test(R) With Anavex Life Sciences Corp.
http://ir.amarantus.com/company-news/detail/1...ences-corp
http://ir.amarantus.com/company-news/detail/1...alzheimers
In addition, the company identified a new, undisclosed biomarker that correlates with AD diagnosis in the LP-002 study (p<0.0001). This new marker could become a central component of a multivariate algorithm (LymPro Score) that is currently being analyzed by company scientists to deliver a simplified assessment of an individual's likelihood of having Alzheimer's disease.
Are you where you want to be in your investment in terms of pps?
Well, even at $10 I won't be where I want to be with mine, but I can wait....
Cheers
Amarantus Commences Launch of Proprietary Alzheimer's Blood Diagnostic LymPro Test(R) to Pharmaceutical Industry for Use in Clinical Trials
http://ir.amarantus.com/company-news/detail/1...cal-trials
Amarantus Announces First Alzheimer's Biomarker Services Collaboration for LymPro Test(R) With Anavex Life Sciences Corp.
http://ir.amarantus.com/company-news/detail/1...ences-corp
http://ir.amarantus.com/company-news/detail/1...alzheimers
In addition, the company identified a new, undisclosed biomarker that correlates with AD diagnosis in the LP-002 study (p<0.0001). This new marker could become a central component of a multivariate algorithm (LymPro Score) that is currently being analyzed by company scientists to deliver a simplified assessment of an individual's likelihood of having Alzheimer's disease.
Are you where you want to be in your investment in terms of pps?
Well, even at $10 I won't be where I want to be with mine, but I can wait....
Cheers
(0)
(0)
